» Articles » PMID: 30867752

MiR-127 Suppresses Gastric Cancer Cell Migration and Invasion Via Targeting Wnt7a

Overview
Journal Oncol Lett
Specialty Oncology
Date 2019 Mar 15
PMID 30867752
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric cancer (GC) is a malignant tumor originating from the mucosal epithelium of the stomach. Patients suffering from this disease may have occurrence of residual GC due to delay in diagnosis and treatment. In addition, abnormal expression of microRNAs (miRNAs) is involved in GC progression. Therefore, we examined the underlying mechanism of miR-127 in GC. The expression of miR-127 and Wnt7a was examined in GC using RT-qPCR and western blot analysis. A Transwell assay was used to assess the ability of GC cell migration and invasion. Luciferase reporter assay was used to verify the specific target of miR-127 in GC. The results showed miR-127 expression was lower in GC than normal samples, while Wnt7a expression was detected at a higher level in GC than normal samples. The association between miR-127 and Wnt7a expression was negatively correlated in GC tissues. miR-127 mimic in the two GC cell lines markedly curbed cell migration and invasion, while inhibition of miR-127 showed the opposite effect. In addition, Wnt7a siRNA significantly inhibited GC cell migration and invasion and Wnt7a was verified as a specific target of miR-127 in GC cells. Wnt7a reversed the ability of GC cell migration and invasion regulated by miR-127. In conclusion, miR-127 could curb GC cell migration and invasion by upregulating Wnt7a, indicating its potential application in GC diagnosis and therapy.

Citing Articles

miR-127/3p Inhibits Cell Migration in Lung Adenocarcinoma Under Hypoxic and Normal Oxygen Conditions.

Lipscomb J, Gray K, Melton T, Nelson P, Rye A, Pruett C MicroPubl Biol. 2024; 2024.

PMID: 39483961 PMC: 11525482. DOI: 10.17912/micropub.biology.001355.


Wnt signaling in gastric cancer: current progress and future prospects.

Han R, Yang J, Zhu Y, Gan R Front Oncol. 2024; 14:1410513.

PMID: 38952556 PMC: 11216096. DOI: 10.3389/fonc.2024.1410513.


The Roles of Secreted Wnt Ligands in Cancer.

Werner J, Boonekamp K, Zhan T, Boutros M Int J Mol Sci. 2023; 24(6).

PMID: 36982422 PMC: 10049518. DOI: 10.3390/ijms24065349.


Integrated analysis identified prognostic microRNAs in breast cancer.

Shang C, Chen Q, Zu F, Ren W BMC Cancer. 2022; 22(1):1170.

PMID: 36371182 PMC: 9652801. DOI: 10.1186/s12885-022-10242-x.


Discovery of benzochalcone derivative as a potential antigastric cancer agent targeting signal transducer and activator of transcription 3 (STAT3).

Dong J, Yang J, Yu W, Li H, Cai M, Xu J J Enzyme Inhib Med Chem. 2022; 37(1):2004-2016.

PMID: 35844184 PMC: 9297716. DOI: 10.1080/14756366.2022.2100366.


References
1.
Doerks T, Copley R, Schultz J, Ponting C, Bork P . Systematic identification of novel protein domain families associated with nuclear functions. Genome Res. 2002; 12(1):47-56. PMC: 155265. DOI: 10.1101/gr.203201. View

2.
Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

3.
Kirikoshi H, Katoh M . Expression of WNT7A in human normal tissues and cancer, and regulation of WNT7A and WNT7B in human cancer. Int J Oncol. 2002; 21(4):895-900. View

4.
Katoh Y, Katoh M . Identification and characterization of rat Wnt6 and Wnt10a genes in silico. Int J Mol Med. 2005; 15(3):527-31. View

5.
Tsai K, Wu C, Hu L, Li S, Liao Y, Lai C . Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Int J Cancer. 2011; 129(11):2600-10. DOI: 10.1002/ijc.25919. View